SNTI
Senti Biosciences Inc
0.3223$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 10,074.9% | 442.6% | 438.7% | – | – | 24.9% | – | – | – | 4,059.1% | – | 3,923.5% | – | |
| 100.0% | -442.6% | -438.7% | – | – | -24.9% | – | – | – | -3,959.1% | 100.0% | -3,823.5% | -4,380.0% | |
| 3,565.5% | 2,739.3% | 2,558.3% | – | – | 128.8% | – | – | – | 35,272.7% | 33,006.3% | 45,688.2% | 56,952.7% | |
| 3,308.6% | 2,101.2% | 2,041.4% | – | – | 155.7% | – | – | – | 26,572.7% | 36,025.0% | 39,641.2% | 43,825.5% | |
| 17,306.3% | 5,091.0% | 4,456.5% | – | – | 251.2% | – | – | – | 57,786.4% | 71,962.5% | 81,405.9% | 100,025.5% | |
| -17,206.3% | -5,533.6% | -4,895.2% | – | – | -276.1% | – | – | – | -61,745.5% | -71,862.5% | -85,229.4% | -102,761.8% | |
| – | 333.9% | 333.9% | – | – | – | – | – | – | – | – | – | – | |
| -14,358.8% | -5,612.0% | -3,636.9% | – | – | -10.4% | – | – | – | -65,759.1% | -26,381.3% | -75,000.0% | -90,116.4% | |
| -932.2% | 8.4% | 8.4% | – | – | 0.0% | – | – | – | – | – | – | – | |
| -5,852.2% | -5,620.4% | -3,636.9% | – | – | -10.4% | – | – | – | -65,759.1% | -26,381.3% | -75,000.0% | -90,116.4% | |
| -6,419.6% | -5,169.4% | -3,198.2% | – | – | 14.5% | – | – | – | -61,700.0% | -22,081.3% | -81,305.9% | -85,818.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.